Matthew R. Silver
Lawyers
Filters
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering
Tuya global offering and dual primary listing on the Hong Kong Stock Exchange
We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
Patria Latin American Opportunity Acquisition $230 million IPO
We advised Patria Latin American Opportunity Acquisition, a SPAC, on its IPO and Nasdaq listing
Marathon Digital Holdings $650 million convertible senior notes offering
We advised Marathon Digital Holdings on its offering of 1% convertible notes due 2026
Telefónica Móviles Chile $500 million senior notes offering
We advised Telefónica Móviles Chile on its investment-grade debt offering